Vericel Corporation (VCEL) Stock Price, Quote & News - Mboum

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 588 5555

Fax: 617 588 5554

Website: www.vcel.com

Address:

64 Sidney Street, Cambridge, United States

ceonner Jun. 30 at 3:37 PM

$VCEL buy at 41, sell at 43.

1 · Reply

copperhat Jun. 30 at 3:19 PM

$VCEL im scared to say it, but i am net positive atm (marginal, but better than a loss).

1 · Reply

copperhat Jun. 27 at 7:59 PM

$VCEL im confused, what is that green stiff?

1 · Reply

copperhat Jun. 27 at 7:51 PM

$VCEL dramatic moves on no vol

0 · Reply

copperhat Jun. 27 at 6:20 PM

$VCEL holy crap, wtf is wrong with this? did i miss some announcement? (Schwab shows no news for vcel, thay are aware of the issue.)

1 · Reply

LAMIGRA Jun. 27 at 4:39 PM

$VCEL why is this on a losing streak?

1 · Reply

Pro_From_Dover Jun. 27 at 4:17 PM

$VCEL managements ‘gift’ to investors

0 · Reply

copperhat Jun. 27 at 2:25 PM

$VCEL miserable

1 · Reply

ceonner Jun. 26 at 6:31 PM

$VCEL projected to be profitable next ER. That will be nice!

1 · Reply

copperhat Jun. 26 at 6:12 PM

$VCEL my apologies, against my better judgment, I added some more. So now this will plummet

0 · Reply

Latest News on VCEL

Vericel Corporation: Moving From Sell To Neutral

Jun 12, 2025, 10:23 AM EDT - 18 days ago

Vericel Corporation: Moving From Sell To Neutral

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Jun 10, 2025, 8:30 AM EDT - 20 days ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 1:52 PM EDT - 7 weeks ago

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 8, 2025, 7:55 AM EDT - 7 weeks ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

May 7, 2025, 8:30 AM EDT - 7 weeks ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:30 AM EDT - 2 months ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Vericel: Scalable Growth With Strong Margins

Mar 5, 2025, 11:56 PM EST - 4 months ago

Vericel: Scalable Growth With Strong Margins

Vericel to Present at Multiple Upcoming Investor Conferences

Mar 4, 2025, 8:30 AM EST - 4 months ago

Vericel to Present at Multiple Upcoming Investor Conferences

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 1:05 PM EST - 4 months ago

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 7:54 AM EST - 4 months ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:30 AM EST - 4 months ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 15, 2025, 8:52 AM EST - 5 months ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Jan 14, 2025, 4:05 PM EST - 5 months ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Vericel Corporation: Hard To Justify Current Valuation

Dec 19, 2024, 12:50 PM EST - 6 months ago

Vericel Corporation: Hard To Justify Current Valuation

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 1:52 PM EST - 8 months ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Vericel Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 7:55 AM EST - 8 months ago

Vericel Reports Third Quarter 2024 Financial Results

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:30 AM EDT - 8 months ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 29, 2024, 9:17 AM EDT - 10 months ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 26, 2024, 7:45 AM EDT - 11 months ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:05 PM EDT - 11 months ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 7, 2024, 8:30 AM EDT - 11 months ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:58 PM EDT - 11 months ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Vericel Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 7:55 AM EDT - 11 months ago

Vericel Reports Second Quarter 2024 Financial Results

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Jun 11, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 2:36 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

May 8, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 11:39 AM EST - 1 year ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 29, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 27, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 15, 2024, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 5, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 9, 2024, 7:55 AM EST - 1 year ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Jan 3, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 2:43 PM EST - 1 year ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 8, 2023, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Present at the Stephens Annual Investment Conference

Nov 7, 2023, 8:30 AM EST - 1 year ago

Vericel to Present at the Stephens Annual Investment Conference

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Oct 25, 2023, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 28, 2023, 8:30 AM EDT - 1 year ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Sep 20, 2023, 4:30 PM EDT - 1 year ago

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Sep 6, 2023, 8:30 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Aug 2, 2023, 7:55 AM EDT - 2 years ago

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Jul 20, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Vericel: Multiyear Growth Catalysts, Proprietary Solutions Will Drive Market Cap Expansion

Jun 27, 2023, 10:57 PM EDT - 2 years ago

Vericel: Multiyear Growth Catalysts, Proprietary Solutions Will Drive Market Cap Expansion

Vericel Corporation (VCEL) Q1 2023 Earnings Call Transcript

May 10, 2023, 11:34 AM EDT - 2 years ago

Vericel Corporation (VCEL) Q1 2023 Earnings Call Transcript

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

May 10, 2023, 7:55 AM EDT - 2 years ago

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D.

May 2, 2023, 9:00 AM EDT - 2 years ago

Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D.

ceonner Jun. 30 at 3:37 PM

$VCEL buy at 41, sell at 43.

1 · Reply

copperhat Jun. 30 at 3:19 PM

$VCEL im scared to say it, but i am net positive atm (marginal, but better than a loss).

1 · Reply

copperhat Jun. 27 at 7:59 PM

$VCEL im confused, what is that green stiff?

1 · Reply

copperhat Jun. 27 at 7:51 PM

$VCEL dramatic moves on no vol

0 · Reply

copperhat Jun. 27 at 6:20 PM

$VCEL holy crap, wtf is wrong with this? did i miss some announcement? (Schwab shows no news for vcel, thay are aware of the issue.)

1 · Reply

LAMIGRA Jun. 27 at 4:39 PM

$VCEL why is this on a losing streak?

1 · Reply

Pro_From_Dover Jun. 27 at 4:17 PM

$VCEL managements ‘gift’ to investors

0 · Reply

copperhat Jun. 27 at 2:25 PM

$VCEL miserable

1 · Reply

ceonner Jun. 26 at 6:31 PM

$VCEL projected to be profitable next ER. That will be nice!

1 · Reply

copperhat Jun. 26 at 6:12 PM

$VCEL my apologies, against my better judgment, I added some more. So now this will plummet

0 · Reply

copperhat Jun. 26 at 5:33 PM

$VCEL remind me to stay out of low vol equities...

0 · Reply

ceonner Jun. 26 at 5:07 PM

$VCEL got my buy limit in! Come on baby, 40.95

1 · Reply

copperhat Jun. 26 at 5:07 PM

$VCEL what the hell?????? Down 7.5%+ atm

0 · Reply

copperhat Jun. 26 at 1:53 PM

$VCEL down 6% in a week. Pos

0 · Reply

ceonner Jun. 25 at 3:02 PM

$VCEL buy at 41, sell at 42…

0 · Reply

copperhat Jun. 25 at 2:05 PM

$VCEL working on my buy high sell low approach

0 · Reply

copperhat Jun. 25 at 12:36 PM

$VCEL i hope the pm price does not last into market opening

0 · Reply

copperhat Jun. 23 at 10:16 PM

$VCEL I wish the ah price lasted into the opening hours

0 · Reply

Pro_From_Dover Jun. 23 at 4:06 PM

$VCEL I suppose premarket was a harbinger of the nonsensical continued drops of this mutha. sheesh-

0 · Reply

Pro_From_Dover Jun. 23 at 4:02 PM

$VCEL Piece_Of_Sh*t

0 · Reply

copperhat Jun. 23 at 1:51 PM

$VCEL miserable crap

0 · Reply

Pro_From_Dover Jun. 23 at 1:22 PM

$VCEL under 40 premarket? Hmmmm.

0 · Reply